J Michael Carroll - Net Worth and Insider Trading
J Michael Carroll Net Worth
The estimated net worth of J Michael Carroll is at least $1 dollars as of 2024-11-13. J Michael Carroll is the Director of Chanticleer Holdings Inc and owns about 3 shares of Chanticleer Holdings Inc (BURG) stock worth over $1. Details can be seen in J Michael Carroll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Michael Carroll has not made any transactions after 2016-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Michael Carroll
J Michael Carroll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Michael Carroll owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of J Michael Carroll’s form 4 insider trades.
Insider Ownership Summary of J Michael Carroll
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SONN | Sonnet BioTherapeutics Holdings Inc | 2005-06-27 | director |
J Michael Carroll Latest Holdings Summary
J Michael Carroll currently owns a total of 1 stock. J Michael Carroll owns 3 shares of Chanticleer Holdings Inc (BURG) as of September 23, 2016, with a value of $1.
Latest Holdings of J Michael Carroll
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BURG | Chanticleer Holdings Inc | 2016-09-23 | 3 | 0.34 | 1 |
Holding Weightings of J Michael Carroll
J Michael Carroll Form 4 Trading Tracker
According to the SEC Form 4 filings, J Michael Carroll has made a total of 0 transactions in Chanticleer Holdings Inc (BURG) over the past 5 years. The most-recent trade in Chanticleer Holdings Inc is the acquisition of 1 shares on September 23, 2016, which cost J Michael Carroll around $2,520.
Insider Trading History of J Michael Carroll
- 1
J Michael Carroll Trading Performance
GuruFocus tracks the stock performance after each of J Michael Carroll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Michael Carroll is -33.82%. GuruFocus also compares J Michael Carroll's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Michael Carroll within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Michael Carroll's insider trading performs compared to the benchmark.
Performance of J Michael Carroll
J Michael Carroll Ownership Network
Ownership Network List of J Michael Carroll
Ownership Network Relation of J Michael Carroll
J Michael Carroll Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
J Michael Carroll is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, J Michael Carroll made no insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN). Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 371,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 2,442 shares were bought by its insiders, resulting in a net purchase of 2,442 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
J Michael Carroll Mailing Address
Above is the net worth, insider trading, and ownership report for J Michael Carroll. You might contact J Michael Carroll via mailing address: 11116 Sithean Way, Richmond Va 23233-2222.